US2011065719A1PendingUtilityA1

Pharmaceutical formulations containing flavouring substances with improved pharmaceutical

Assignee: BAYER ANIMAL HEALTH GMBHPriority: Nov 4, 2003Filed: Nov 19, 2010Published: Mar 17, 2011
Est. expiryNov 4, 2023(expired)· nominal 20-yr term from priority
A61P 31/00A61P 31/04A61K 9/2068A61K 9/2059A61K 9/2018A61K 9/0056A61K 31/495A61K 33/00
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to flavouring-containing pharmaceutical formulations with improved pharmaceutical properties, and to process for the production thereof.

Claims

exact text as granted — not AI-modified
1 . Solid pharmaceutical formulation comprising an active pharmaceutical ingredient, a flavouring and at least 1.5% by weight of colloidal silicon dioxide based on the total weight of the finished formulation. 
     
     
         2 . Solid pharmaceutical formulation according to  claim 1 , comprising as active pharmaceutical ingredients enrofloxacin, an enrofloxacin salt or a hydrate of enrofloxacin or of its salt. 
     
     
         3 . Solid pharmaceutical formulation according to  claim 1 , comprising as active pharmaceutical ingredient pradofloxacin, a pradofloxacin salt or a hydrate of pradofloxacin or of its salt. 
     
     
         4 . Process for producing the solid pharmaceutical formulation according to  claim 1 , in which the flavouring is granulated with the colloidal silicon dioxide and with one or more active ingredients and pharmaceutically customary additives and/or excipients.

Join the waitlist — get patent alerts

Track US2011065719A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.